publication date: Dec. 20, 2010

In this issue: 

CMS develops new math of Medicare: Reimbursement money for outcomes data.

Decision to cover new colorectal cancer drugs, PET scans.

Also in this 8-page issue: In overhaul of ethics rules, NIH bans employees from consulting for and owning stock in biomedical companies.

Download (PDF 291KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.